In contrast, BRCA-specific genes included CDO1 (cysteine dioxygenase Type 1, whose inactivation was recently reported to contribute to survival and drug resistance in breast cancer [31]) and a number of genes involved in glycerolipid/lipid biosynthesis and associated with malignancy in breast cancer (GPAM [32] and MGLL [33]). This evidence concerns the gene MGLL and breast cancer.